111 research outputs found
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
CNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTĂFICO E TECNOLĂGICOBrain metastases develop frequently in patients with breast cancer, and present a pressing therapeutic challenge. Expression of vascular cell adhesion molecule 1 (VCAM-1) is upregulated on brain endothelial cells during the early stages of metastasis and provides a target for the detection and treatment of early brain metastases. The aim of this study was to use a model of early brain metastasis to evaluate the efficacy of a-emitting radionuclides, Tb-149, At-211, Pb-212, Bi-213 and Ac-225|| beta-emitting radionuclides, Y-90, Tb-161 and Lu-177|| and Auger electron (AE)-emitters Ga-67, Zr-89, In-111 and I-124, for targeted radionuclide therapy (TRT). METHODS: Histologic sections and two photon microscopy of mouse brain parenchyma were used to inform a cylindrical vessel geometry using the Geant4 general purpose Monte Carlo (MC) toolkit with the Geant4-DNA low energy physics models. Energy deposition was evaluated as a radial function and the resulting phase spaces were superimposed on a DNA model to estimate double-strand break (DSB) yields for representative beta- and alpha-emitters, Lu-177 and Pb-212. Relative biological effectiveness (RBE) values were determined by only evaluating DNA damage due to physical interactions. RESULTS: Lu-177 produced 2.69 +/- 0.08 DSB per GbpGy, without significant variation from the lumen of the vessel to a radius of 100 mu m. The DSB yield of Pb-212 included two local maxima produced by the 6.1 MeV and 8.8 MeV alpha-emissions from decay products, Bi-212 and Po-212, with yields of 7.64 +/- 0.12 and 9.15 +/- 0.24 per GbpGy, respectively. Given its higher DSB yield Pb-212 may be more effective for short range targeting of early micrometastatic lesions than Lu-177. CONCLUSION: MC simulation of a model of early brain metastases provides invaluable insight into the potential efficacy of alpha-, beta- and AE-emitting radionuclides for TRT. Pb-212, which has the attributes of a theranostic radionuclide since it can be used for SPECT imaging, showed a favorable dose profile and RBE.81292303CNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTĂFICO E TECNOLĂGICOCNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTĂFICO E TECNOLĂGICO306775/2015-8190154/2013-6AgĂȘncias de fomento estrangeiras apoiaram essa pesquisa, mais informaçÔes acesse artig
FLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study
Radiothérapie de demain pour le traitement du cancer. Conférence GIP CYCERON
CERVOXYNational audienc
L'Imagerie médicale en Radiophysique au Centre François Baclesse : Pour une médecine personnalisée
National audienc
Existe-t-il un lien entre localisation et réponse thérapeutique des métastases cérébrales ?
CERVOXYNational audienc
Existe-t-il un lien entre localisation et réponse thérapeutique des métastases cérébrales ?
CERVOXYNational audienc
Impact du dĂ©bruitage par intelligence artificiel sur les radiomics extrait dâexamen PET au FDG
CERVOXYNational audienc
Impact du dĂ©bruitage par intelligence artificiel sur les radiomics extrait dâexamen PET au FDG
CERVOXYNational audienc
- âŠ